Research objective was to detail COVID-19's natural trajectory in relation to the Czech population's viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19's impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median-19 days). The highest viral load occurred within 0-2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation.

Department of Anesthesiology and Intensive Care Medicine Masaryk University and University Hospital Brno Brno Czech Republic

Department of Infectious Diseases Masaryk University and University Hospital Brno Brno Czech Republic

Department of Internal Medicine Geriatrics and Practical Medicine Masaryk University and University Hospital Brno Brno Czech Republic

Department of Internal Medicine Hematology and Oncology Masaryk University and University Hospital Brno Brno Czech Republic

Department of Mathematics and Statistics Faculty of Science Masaryk University Brno Czech Republic

Department of Nursing and Midwifery Faculty of Medicine Masaryk University Brno Czech Republic

Department of Radiology and Nuclear Medicine Masaryk University and University Hospital Brno Brno Czech Republic

Department of Respiratory Diseases Masaryk University and University Hospital Brno Brno Czech Republic

General Practitioner's Office Berkova 2390 107 61200 Brno Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 20 Dec 2020.

Borges do Nascimento, I. J. et al. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses. PLoS One.15, e0239235 (2020). PubMed PMC

Struyf T, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst. Rev. 2020;7:CD013665. PubMed PMC

Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:993–998. doi: 10.15585/mmwr.mm6930e1. PubMed DOI PMC

Jung C-Y, et al. Clinical characteristics of asymptomatic patients with COVID-19: A Nationwide Cohort Study in South Korea. Int. J. Infect. Dis. 2020;99:266–268. doi: 10.1016/j.ijid.2020.08.001. PubMed DOI PMC

Paderno A, et al. Olfactory and gustatory outcomes in COVID-19: A prospective evaluation in nonhospitalized subjects. Otolaryngol. Head Neck Surg. 2020;163:1144–1149. doi: 10.1177/0194599820939538. PubMed DOI PMC

Speth MM, et al. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated characteristics. Otolaryngol. Head Neck Surg. 2020;163:114–120. doi: 10.1177/0194599820929185. PubMed DOI PMC

Beigel JH, et al. Remdesivir for the treatment of Covid-19—Final report. N. Engl. J. Med. 2020;383:1813–1826. doi: 10.1056/NEJMoa2007764. PubMed DOI PMC

Gupta S, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern. Med. 2020 doi: 10.1001/jamainternmed.2020.6252. PubMed DOI PMC

Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2034577. PubMed DOI PMC

Kalil AC, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2031994. PubMed DOI PMC

Lechien JR, Barillari MR, Jouffe L, Saussez S. Anosmia is a key symptom of COVID-19 infection and should be used as a diagnostic tool. Ear Nose Throat J. 2020;99:577–578. doi: 10.1177/0145561320925191. PubMed DOI

Pang KW, Chee J, Subramaniam S, Ng CL. Frequency and clinical utility of olfactory dysfunction in COVID-19: A systematic review and meta-analysis. Curr. Allergy Asthma Rep. 2020;20:76. doi: 10.1007/s11882-020-00972-y. PubMed DOI PMC

Cheng A, Caruso D, McDougall C. Outpatient management of COVID-19: Rapid evidence review. Am. Fam. Phys. 2020;102:478–486. PubMed

Dixon BE, et al. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study. medRxiv. 2020 doi: 10.1101/2020.10.11.20210922. PubMed DOI PMC

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2007621. PubMed DOI PMC

Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323:1574–1581. doi: 10.1001/jama.2020.5394. PubMed DOI PMC

Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. PubMed DOI PMC

Chang MC, Lee W, Hur J, Park D. Chest computed tomography findings in asymptomatic patients with COVID-19. Respiration. 2020;99:748–754. doi: 10.1159/000509334. PubMed DOI PMC

Meng H, et al. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China. J. Infect. 2020;81:e33–e39. doi: 10.1016/j.jinf.2020.04.004. PubMed DOI PMC

Pan Y, et al. Epidemiological and clinical characteristics of 26 asymptomatic severe acute respiratory syndrome coronavirus 2 carriers. J. Infect. Dis. 2020;221:1940–1947. doi: 10.1093/infdis/jiaa205. PubMed DOI PMC

Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346. PubMed DOI PMC

Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N. Engl. J. Med. 2020;382:2534–2543. doi: 10.1056/NEJMsa2011686. PubMed DOI PMC

Falasca L, et al. Postmortem findings in Italian patients with COVID-19: A descriptive full autopsy study of cases with and without comorbidities. J. Infect. Dis. 2020;222:1807–1815. doi: 10.1093/infdis/jiaa578. PubMed DOI PMC

Guan W-J, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur. Respir. J. 2020;55:2001227. doi: 10.1183/13993003.01227-2020. PubMed DOI PMC

Keshvardoost S, Bahaadinbeigy K, Fatehi F. Role of telehealth in the management of COVID-19: Lessons learned from previous SARS, MERS, and ebola outbreaks. Telemed. J. E Health. 2020;26:850–852. doi: 10.1089/tmj.2020.0105. PubMed DOI

http://www.szu.cz/uploads/Epidemiologie/Coronavirus/26032020_mz/Kriteria_pro_propusteni_pacienta_z_izolace_25032020_final_.pdf. Accessed 20 Dec 2020.

https://koronavirus.mzcr.cz/ministerstvo-zdravotnictvi-aktualizovalo-algoritmus-k-ukonceni-karanteny/. Accessed 15 Jan 2021.

Komenda M, et al. Complex reporting of the COVID-19 epidemic in the Czech Republic: Use of an interactive web-based app in practice. J. Med. Internet Res. 2020;22:e19367. doi: 10.2196/19367. PubMed DOI PMC

Margraf J, Brailovskaia J, Schneider S. Behavioral measures to fight COVID-19: An 8-country study of perceived usefulness, adherence and their predictors. PLoS ONE. 2020;15:e0243523. doi: 10.1371/journal.pone.0243523. PubMed DOI PMC

Niklassen AS, et al. COVID-19: Recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. 2021;131:1095–1100. doi: 10.1002/lary.29383. PubMed DOI

Huart C, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. 2020;58:623–625. PubMed

http://www.szu.cz/uploads/Epidemiologie/Coronavirus/MZ_CR/Mimoradne_opatreni_izolace_a_karantena_s_ucinnosti_od_25._9._2020_do_odvolani.pdf.

Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585:339–341. doi: 10.1038/d41586-020-02598-6. PubMed DOI

Izcovich A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS ONE. 2020;15:e0241955. doi: 10.1371/journal.pone.0241955. PubMed DOI PMC

Zhang X, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583:437–440. doi: 10.1038/s41586-020-2355-0. PubMed DOI

Ko JY, et al. Risk factors for COVID-19-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1419. PubMed DOI PMC

Chu DK, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. Lancet. 2020;395:1973–1987. doi: 10.1016/S0140-6736(20)31142-9. PubMed DOI PMC

Hu F, et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol. Immunol. 2020;17:1119–1125. doi: 10.1038/s41423-020-00550-2. PubMed DOI PMC

Pietsch H, et al. Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection. Int. J. Infect. Dis. 2020;102:70–72. doi: 10.1016/j.ijid.2020.10.012. PubMed DOI PMC

Akinosoglou K, et al. SARS-CoV-2 persistence and non-protective immunity in infected haematological patients. Br. J. Haematol. 2020 doi: 10.1111/bjh.17212. PubMed DOI PMC

Jaafar R, et al. Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1491. PubMed DOI PMC

Laferl H, et al. An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA. Infection. 2020 doi: 10.1007/s15010-020-01530-4. PubMed DOI PMC

He S, et al. Clinical characteristics of ‘re-positive’ discharged COVID-19 pneumonia patients in Wuhan, China. Sci. Rep. 2020;10:17365. doi: 10.1038/s41598-020-74284-6. PubMed DOI PMC

Walsh KA, et al. The duration of infectiousness of individuals infected with SARS-CoV-2. J. Infect. 2020;81:847–856. doi: 10.1016/j.jinf.2020.10.009. PubMed DOI PMC

Fontana LM, Villamagna AH, Sikka MK, McGregor JC. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect. Control Hosp. Epidemiol. 2020 doi: 10.1017/ice.2020.1273. PubMed DOI PMC